Vaccination, consent and multidose vials

Medical Journal of Australia

Volumn 194, Issue 8, 2011, Pages 414-416

  Diamond, Mark R ^a   O'Brien Malone, Angela ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADVERSE OUTCOME; ARTICLE; AUSTRALIA; DRUG CONTAMINATION; DRUG SAFETY; GOOD CLINICAL PRACTICE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; INFECTION RISK; INFORMED CONSENT; MASS IMMUNIZATION; MEDICAL LIABILITY; PATIENT EDUCATION; PATIENT INFORMATION; PROFESSIONAL COMPETENCE;

EID: 79955517496     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2011.tb03033.x     Document Type: Article

References (25)

1. Plueckhahn VD, Banks J. Fatal haemolytic streptococcal septicaemia following mass inoculation with influenza vaccine. Med J Aust 1970; 1: 405-411.
2. Phadke MA, Joshi BN, Warerkar UV, et al. Toxic shock syndrome: an unforeseen complication following measles vaccination. Indian Pediatr 1991; 28: 663-665.
3. Katzenstein TL, Jorgensen LB, Permin H, et al. Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS 1999; 13: 1737-1744.
4. Feinmann J. Doctors call for ban on multidose vials after hepatitis C outbreak in US. BMJ 2010; 341: c4057.
5. Gosbell IB, Gottlieb T, Kesson AM, et al. Immunisation and multi-dose vials. Vaccine 2010; 28: 6556-6561.
6. Rosendorff D. Doctors warn: swine flu vaccine poses too many risks [radio transcript]. PM. Radio National. Australian Broadcasting Commission. 20 Aug 2009. http://www.abc.net.au/pm/content/2008/s2662248.htm (accessed Mar 2011).
7. Australian Government Department of Health and Ageing. Interim infection control guidelines for pandemic influenza in healthcare and community settings. June 2006. Annex to Australian Health Management Plan for Pandemic Influenza. Canberra: Commonwealth of Australia, 2006.
8. Australian Technical Advisory Group on Immunisation. Guideline for the administration of pandemic (H1N1) influenza vaccine from multi-dose vials (MDV). Canberra: Australian Government Department of Health and Ageing and Royal Australian College of General Practitioners, 2009. http://www.health.gov.au/internet/healthemergency/publishing.nsf/Content/2723D54E78BF5739CA2576400027E1E9/$File/6013%20H1N1%20MDV%20Protocol%20v3%20CMYK%20SCREEN.pdf (accessed Mar 2011).
9. Australian Government Department of Health and Ageing. Getting the Panvax vaccine for pandemic (H1N1) 2009 influenza. Canberra: DoHA, 2009. http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/2723D54E78BF5739CA2576400027E1E9/$File/information%20sheet%20children.pdf (accessed Mar 2011).
10. Australian Government Department of Health and Ageing. Pandemic (H1N1) 2009 influenza vaccine consent form. Canberra: DoHA, 2009. http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/2723D54E78BF5739CA2576400027E1E9/$File/6013%20H1N1%20Priority%20-%20Consent%20Form%20Web.pdf (accessed Mar 2011).
11. Sidaway v Board of Governors of the Bethlem Royal Hospital [1985] UKHL 1.
12. Rogers v Whitaker (1992) 175 CLR 479.
13. Chappel v Hart (1998) 195 CLR 232.
14. Australian Technical Advisory Group on Immunisation. ATAGI statement: Use of multi-dose vials in vaccination programs. Canberra: DoHA, 2009. http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/national-vaccination-program#atagi (accessed Mar 2011).
15. Australian Government Department of Health and Ageing; National Health and Medical Research Council. The Australian immunization handbook. 9th ed. Canberra: Commonwealth of Australia, 2008.
16. Stapley v Fisher [2003] WADC 278.
17. Stetler HC, Garbe PL, Dwyer DM, et al. Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Pediatrics 1985; 75: 299-303.
18. Borghans JG, Stanford JL. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 1973; 107: 1-8.
19. Simon PA, Chen RT, Elliott JA, Schwartz B. Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination. Pediatr Infect Dis J 1993; 12: 368-371.
20. Kellaway CH, MacCallum P, Tebbutt AH. The fatalities at Bundaberg. Report of the Royal Commission. Med J Aust 1928; 2: 2-19.
21. Becker NG. Infectious disease models. In: Gail MH, Benichou J, editors. Encyclopedia of epidemiologic methods. Chichester, UK: John Wiley and Sons, 2000: 447-450.
22. Montella M, Crispo A, Grimaldi M, et al. Assessment of iatrogenic transmission of HCV in southern Italy: was the cause the Salk polio vaccination? J Med Virol 2003; 70: 49-50.
23. Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-1011.
24. Bujia J, Wilmes E, Kastenbauer E, Gurtler L. Influence of chemical allograft preservation procedures on the human immunodeficiency virus. Laryngoscope 1996; 106: 645-647.
25. Council of Australian Governments; Working Group on Australian Influenza Pandemic Prevention and Preparedness. National Action Plan for Human Influenza Pandemic. Canberra: Department of Prime Minister and Cabinet, 2010.